Alion Awarded DTRA CWMD Contract Valued at up to $4Bn
- Engineering Solutions Firm to Perform Research & Technology Development and Test & Evaluation to Help Reduce Proliferation of WMD Threats
Worldwide, weapons of mass destruction (WMD), including chemical, biological, radiological, nuclear, and high-yield explosives (CBRNE), are a continuing concern to America and its allies. To address this ongoing challenge, Alion Science and Technology, a global engineering, technology and operational solutions company, was awarded a contract to compete for $4 billion in work to support the Defense Threat Reduction Agency’s (DTRA’s) efforts to counter weapons of mass destruction (CWMD).
Under the five-year base period of performance plus a five-year option period contract, the Alion team will compete for individual task orders to perform research and development, hardware and software technology development, and test and evaluation across the CWMD landscape. The results will help DTRA to find and deploy solutions to counter the proliferation of, and threat posed by, potential WMD devices.
Global Biodefense Market Size, Status and Forecast 2022
“This contract will allow Alion to expand on our previous 10 years of support to DTRA in nuclear detection, modeling and simulation, exercise support and systems analysis,” said Terri Spoonhour, Alion Senior Vice President and Distributed Simulation Group Manager. “We have assembled a team that includes small businesses, large businesses, not-for-profit research companies and universities – each demonstrating proven capability to support and advance the CWMD mission over a range of critical functional areas.”
Alion is one of only seven awardees chosen to compete for work under the DTRA contract.
DTRA is the U.S. Department of Defense’s Combat Support Agency for countering weapons of mass destruction across the entire spectrum of chemical, biological, radiological, nuclear and high-yield explosive threats. DTRA’s programs include basic science research and development, operational support to U.S. warfighters on the front line and an in-house WMD think tank that aims to anticipate and mitigate future threats long before they have a chance to harm the United States and its Allies.
Source : Alion Science and Technology Corp. - view original press release